Tom 5, Nr 3 (2020)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2020-12-07
Wyświetlenia strony 494
Wyświetlenia/pobrania artykułu 155
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Stanowisko Ekspertów Ogólnopolskiego Programu Zwalczania Grypy oraz Polskiego Towarzystwa Ginekologów i Położników dotyczące szczepienia przeciw grypie kobiet w ciąży

Adam Antczak1, Ernest Kuchar2, Aneta Nitch-Osuch3, Piotr Sieroszewski4, Mirosław Wielgoś45, Mariusz Zimmer6
Ginekologia i Perinatologia Praktyczna 2020;5(3):112-118.

Streszczenie

Brak

Referencje

  1. Kassianos G, Blank P, Falup-Pecurariu O, et al. Influenza vaccination: key facts for general practitioners in Europe-a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands. Drugs Context. 2016; 5: 212293.
  2. World Health Organization (WHO). Influenza seasonal. Https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal) (11.04.2020).
  3. Meldunki epidemiologiczne. www.pzh.gov.pl (1.07.2020).
  4. Nitsch-Osuch A. Przydatność́ wykonywania szybkich testów diagnostycznych w kierunku grypy u dzieci w wieku 0-5 lat – ocena wiarygodności i implikacje kliniczne. Rozprawa habilitacyjna. Oficyna wydawnicza, Warszawski Uniwersytet Medyczny. 2013.
  5. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014; 370(23): 2211–2218.
  6. Siston A. Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States. JAMA. 2010; 303(15): 1517.
  7. Meijer WJ, van Noortwijk AGA, Bruinse HW, et al. Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand. 2015; 94(8): 797–819.
  8. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998; 148(11): 1094–1102.
  9. Mazagatos C, Delgado-Sanz C, Oliva J, et al. Spanish Influenza Surveillance System. Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16. PLoS One. 2018; 13(8): e0200934.
  10. Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. 2013; 2013: 752852.
  11. Creanga AA, Johnson TF, Graitcer SB, et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol. 2010; 115(4): 717–726.
  12. Håberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013; 368(4): 333–340.
  13. Piechota Z, Botiuk K, Skręt A, et al. Severe a/h1n1 influenza in four pregnant women in podkarpacie province of Poland. Ginekol Pol. 2010; 81(3): 227–231.
  14. Hamela-Olkowska A, Szymkiewicz-Dangel J. Tachyarytmie u płodów – aktualny stan wiedzy. Ginekol Pol. 2010; 81: 844–850.
  15. Stanwell-Smith R, Parker AM, Chakraverty P, et al. Possible association of influenza A with fetal loss: investigation of a cluster of spontaneous abortions and stillbirths. Commun Dis Rep CDR Rev. 1994; 4(3): R28–R32.
  16. Håberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med. 2013; 368(4): 333–340.
  17. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol. 2011; 205(1): 10–18.
  18. Valvi C, Kulkarni R, Kinikar A, et al. 2009H1N1 Infection in a 1-day-old neonate. Indian Journal of Medical Sciences. 2010; 64(12): 552.
  19. Picone O, Bernabe-Dupont C, Vauloup-Fellous C, et al. [A suspected case of in utero transmission of influenza A (H1N1) 2009]. J Gynecol Obstet Biol Reprod (Paris). 2011; 40(5): 473–475.
  20. Chaves SS, Perez A, Farley MM, et al. Influenza Hospitalization Surveillance Network. The burden of influenza hospitalizations in infants from 2003 to 2012, United States. Pediatr Infect Dis J. 2014; 33(9): 912–919.
  21. Poehling KA, Edwards KM, Weinberg GA, et al. New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med. 2006; 355(1): 31–40.
  22. Prevention and Control of Influenza Recommendations of the Immunization Practices Advisory Committee (ACIP). PsycEXTRA Dataset. 1990.
  23. World Health Organization (WHO). Influenza vaccination of women during pregnancy. https://www.who.int/vaccine_safety/committee/topics/influenza/pregnancy/en/.
  24. American College of Obstetricians and Gynecologists Committee on Obstetric Practice (ACOG). 2004: Influenza vaccination and treatment during pregnancy. Obstet Gynecol. 2004; 104(5): 1125–1126.
  25. Komunikat Głównego Inspektora Sanitarnego z dnia 16 października 2019 r. W sprawie Programu Szczepień Ochronnych na rok 2020. http://dziennikmz.mz.gov.pl/api/dum_mz/2019/87/journal/5727 (24.4.2020).
  26. Brydak L, Nitsch-Osuch A. Vaccination against influenza in pregnant women. Acta Biochimica Polonica. 2014; 61(3).
  27. Charakterystyka produktu leczniczego VaxigripTetra. File:///c:/users/epidemiolog/downloads/charakterystyka-35346-20200514000000-619_oli-20200515001304.pdf (1.07.2020).
  28. Charakterystyka produktu leczniczego Influvac Tetra. file:///c::/users/epidemiolog/downloads/charakterystyka-37540-20200514000000-617_oli-20200519000435%20(3).pdf (1.07.2020).
  29. Charakterystyka produktu leczniczego Fluenz Tetra. Https://www.astrazeneca.pl/content/dam/az-pl/spc/spc_fluenztetra_2019-08-23.pdf (1.07.2020).
  30. Moro P, Baumblatt J, Lewis P, et al. Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016. Drug Saf. 2017; 40(2): 145–152.
  31. Nordin JD, Kharbanda EO, Benitez GV, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013; 121(3): 519–525.
  32. Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Vaccine Safety Datalink Team. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013; 122(3): 659–667.
  33. Giles ML, Krishnaswamy S, Macartney K, et al. The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Hum Vaccin Immunother. 2019; 15(3): 687–699.
  34. Bratton K, Wardle M, Orenstein W, et al. Maternal Influenza Immunization and Birth Outcomes of Stillbirth and Spontaneous Abortion: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 2014; 60(5): e11–e19.
  35. Trotta F, Cas RDa, Alegiani SS, et al. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ. 2014; 348(may29 5): g3361–g3361.
  36. Cantu J, Tita ATN. Management of influenza in pregnancy. Am J Perinatol. 2013; 30(2): 99–103.
  37. Ohfuji S, Fukushima W, Deguchi M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis. 2011; 203(9): 1301–1308.
  38. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008; 359(15): 1555–1564.
  39. Thompson MG, Li DK, Shifflett P, et al. Pregnancy and Influenza Project Workgroup. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis. 2014; 58(4): 449–457.
  40. Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews. 2018.
  41. Thompson MG, Kwong JC, Regan AK, et al. PREVENT Workgroup. Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016. Clin Infect Dis. 2019; 68(9): 1444–1453.
  42. Fell D, Johnson J, Mor Z, et al. Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review. BMJ Open. 2017; 7(9): e016526.
  43. Puck JM, Glezen WP, Frank AL, et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis. 1980; 142(6): 844–849.
  44. Madhi S, Cutland C, Kuwanda L, et al. Influenza Vaccination of Pregnant Women and Protection of Their Infants. New England Journal of Medicine. 2014; 371(10): 918–931.
  45. Tapia MD, Sow SO, Tamboura B, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis. 2016; 16(9): 1026–1035.
  46. Omer SB, Clark DR, Aqil AR, et al. for BMGF Supported Maternal Influenza Immunization Trials Investigators Group. Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali and South Africa. Pediatr Infect Dis J. 2018; 37(5): 436–440.
  47. Benowitz I, Esposito DB, Gracey KD, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010; 51(12): 1355–1361.
  48. Steinhoff M, Katz J, Englund J, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. The Lancet Infectious Diseases. 2017; 17(9): 981–989.



Ginekologia i Perinatologia Praktyczna